The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma

Therapeutic Advances in Respiratory Disease

Volumn 10, Issue 2, 2016, Pages 158-174

  Hewitt, Richard ^a   Farne, Hugo ^a   Ritchie, Andrew ^a   Luke, Emma ^b   Johnston, Sebastian L ^b   Mallia, Patrick ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

asthma; bacteria; COPD; respiratory viruses

Indexed keywords

ANTIVIRUS AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; DUPILUMAB; LEBRIKIZUMAB; LONG ACTING DRUG; MEPOLIZUMAB; MUSCARINIC RECEPTOR BLOCKING AGENT; OMALIZUMAB; RESLIZUMAB; TRALOKINUMAB; ANTIASTHMATIC AGENT; BRONCHODILATING AGENT;

ACUTE DISEASE; AIRWAY OBSTRUCTION; ASTHMA; BACTERIAL INFECTION; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; EVIDENCE BASED MEDICINE; EXPERIMENTAL INFECTION; GENETIC SUSCEPTIBILITY; HEALTH CARE COST; HUMAN; HUMAN BOCAVIRUS; HUMAN METAPNEUMOVIRUS; HUMAN RHINOVIRUS C; IMMUNE DEFICIENCY; INNATE IMMUNITY; MIXED INFECTION; MORBIDITY; MORTALITY; NONHUMAN; ORGANISMAL INTERACTION; PANDEMIC INFLUENZA; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RHINOVIRUS; RHINOVIRUS INFECTION; SYMPTOM; VIRAL RESPIRATORY TRACT INFECTION; DRUG EFFECTS; HOST PATHOGEN INTERACTION; ISOLATION AND PURIFICATION; LUNG; MICROBIOLOGY; PATHOGENICITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY TRACT INFECTIONS; RISK FACTOR; VIROLOGY; VIRUS; VIRUS DISEASES;

ANTI-ASTHMATIC AGENTS; ANTIVIRAL AGENTS; ASTHMA; BACTERIAL INFECTIONS; BRONCHODILATOR AGENTS; COINFECTION; DISEASE PROGRESSION; HOST-PATHOGEN INTERACTIONS; HUMANS; LUNG; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; VIRUS DISEASES; VIRUSES;

EID: 84960501644     PISSN: 17534658     EISSN: 17534666     Source Type: Journal    
DOI: 10.1177/1753465815618113     Document Type: Review

References (140)

1. Albert R., Connett J., Bailey W., Casaburi R., Cooper J. Jr, Criner G., et al. (2011) Azithromycin for prevention of exacerbations of COPD. N Engl J Med 365: 689-698.
2. Almansa R., Sanchez-Garcia M., Herrero A., Calzada S., Roig V., Barbado J., et al. (2011) Host response cytokine signatures in viral and nonviral acute exacerbations of chronic obstructive pulmonary disease. J Interferon Cytokine Res 31: 409-413.
3. Arden K., Chang A., Lambert S., Nissen M., Sloots T., Mackay I., (2010) Newly identified respiratory viruses in children with asthma exacerbation not requiring admission to hospital. J Med Virol 82: 1458-1461.
4. Bafadhel M., McKenna S., Terry S., Mistry V., Reid C., Haldar P., et al. (2011) Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med 184: 662-671.
5. Baines K., Hsu A., Tooze M., Gunawardhana L., Gibson P., Wark P., (2013) Novel immune genes associated with excessive inflammatory and antiviral responses to rhinovirus in COPD. Respir Res 14: 15.
6. Bandi V., Jakubowycz M., Kinyon C., Mason E., Atmar R., Greenberg S., et al. (2003) Infectious exacerbations of chronic obstructive pulmonary disease associated with respiratory viruses and non-typeable Haemophilus influenzae. FEMS Immunol Med Microbiol 37: 69-75.
7. Baraldo S., Contoli M., Bazzan E., Turato G., Padovani A., Marku B., et al. (2012) Deficient antiviral immune responses in childhood: distinct roles of atopy and asthma. J Allergy Clin Immunol 130: 1307-1314.
8. Bateman E., Hurd S., Barnes P., Bousquet J., Drazen J., Fitzgerald M., et al. (2008) Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31: 143-178.
9. Beasley R., Coleman E., Hermon Y., Holst P., O'Donnell T., Tobias M., (1988) Viral respiratory tract infection and exacerbations of asthma in adult patients. Thorax 43: 679-683.
10. Beckham J., Cadena A., Lin J., Piedra P., Glezen W., Greenberg S., et al. (2005) Respiratory viral infections in patients with chronic, obstructive pulmonary disease. J Infect 50: 322-330.
11. Bizzintino J., Lee W., Laing I., Vang F., Pappas T., Zhang G., et al. (2011) Association between human rhinovirus C and severity of acute asthma in children. Eur Respir J 37: 1037-1042.
12. Bochkov Y., Hanson K., Keles S., Brockman-Schneider R., Jarjour N., Gern J., (2010) Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma. Mucosal Immunol 3: 69-80.
13. Bossios A., Gourgiotis D., Skevaki C., Saxoni-Papageorgiou P., Lotvall J., Psarras S., et al. (2008) Rhinovirus infection and house dust mite exposure synergize in inducing bronchial epithelial cell interleukin-8 release. Clin Exp Allergy 38: 1615-1626.
14. Bossios A., Psarras S., Gourgiotis D., Skevaki C., Constantopoulos A., Saxoni-Papageorgiou P., et al. (2005) Rhinovirus infection induces cytotoxicity and delays wound healing in bronchial epithelial cells. Respir Res 6: 114.
15. Bozinovski S., Hutchinson A., Thompson M., MacGregor L., Black J., Giannakis E., et al. (2008) Serum amyloid A is a biomarker of acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177: 269-278.
16. Bramley A., Dasgupta S., Skarbinski J., Kamimoto L., Fry A., Finelli L., et al. (2012) Intensive care unit patients with 2009 pandemic influenza A (H1N1pdm09) virus infection-United States, 2009. Influenza Other Respir Viruses 6: e134-e142.
17. Brightling C., Chanez P., Leigh R., O'Byrne P., Korn S., She D., et al. (2015) Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial. Lancet Respir Med 3: 692-701.
18. Buscho R., Saxtan D., Shultz P., Finch E., Mufson M., (1978) Infections with viruses and Mycoplasma pneumoniae during exacerbations of chronic bronchitis. J Infect Dis 137: 377-383.
19. Cakebread J., Xu Y., Grainge C., Kehagia V., Howarth P., Holgate S., et al. (2011) Exogenous IFN-beta has antiviral and anti-inflammatory properties in primary bronchial epithelial cells from asthmatic subjects exposed to rhinovirus. J Allergy Clin Immunol 127: 1148-1154.
20. Calvo C., Casas I., Garcia-Garcia M., Pozo F., Reyes N., Cruz N., et al. (2010) Role of rhinovirus C respiratory infections in sick and healthy children in Spain. Pediatr Infect Dis J 29: 717-720.
21. Camargo C. Jr, Ginde A., Clark S., Cartwright C., Falsey A., Niewoehner D., (2008) Viral pathogens in acute exacerbations of chronic obstructive pulmonary disease. Intern Emerg Med 3: 355-359.
22. Cameron R., De Wit D., Welsh T., Ferguson J., Grissell T., Rye P., (2006) Virus infection in exacerbations of chronic obstructive pulmonary disease requiring ventilation. Intensive Care Med 32: 1022-1029.
23. Castro M., Zangrilli J., Wechsler M., Bateman E., Brusselle G., Bardin P., et al. (2015) Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet Respir Med 3: 355-366.
24. Contoli M., Ito K., Padovani A., Poletti D., Marku B., Edwards M., et al. (2015) Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells. Allergy 70: 910-920.
25. Contoli M., Message S., Laza-Stanca V., Edwards M., Wark P., Bartlett N., et al. (2006) Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 12: 1023-1026.
26. Corren J., Lemanske R., Hanania N., Korenblat P., Parsey M., Arron J., et al. (2011) Lebrikizumab treatment in adults with asthma. N Engl J Med 365: 1088-1098.
27. Cox D., Bizzintino J., Ferrari G., Khoo S., Zhang G., Whelan S., et al. (2013) Human rhinovirus species C infection in young children with acute wheeze is associated with increased acute respiratory hospital admissions. Am J Respir Crit Care Med 188: 1358-1364.
28. Daubin C., Parienti J., Vabret A., Ramakers M., Fradin S., Terzi N., et al. (2008) Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study. BMC Infect Dis 8: 145.
29. Dawood F., Kamimoto L., D'Mello T., Reingold A., Gershman K., Meek J., et al. (2011) Children with asthma hospitalized with seasonal or pandemic influenza, 2003-2009. Pediatrics 128: e27-e32.
30. De Miguel-Diez J., Carrasco-Garrido P., Hernandez-Barrera V., Rodriguez-Rodriguez P., Puente-Maestu L., De Miguel A., et al. (2012) Hospitalizations from pandemic influenza (pH1N1) infections among patients with asthma or COPD in Spain. J Infect 65: 95-98.
31. De Serres G., Lampron N., La Forge J., Rouleau I., Bourbeau J., Weiss K., et al. (2009) Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations. J Clin Virol 46: 129-133.
32. Di Stefano A., Maestrelli P., Roggeri A., Turato G., Calabro S., Potena A., et al. (1994) Upregulation of adhesion molecules in the bronchial mucosa of subjects with chronic obstructive bronchitis. Am J Respir Crit Care Med 149: 803-810.
33. Dimopoulos G., Lerikou M., Tsiodras S., Chranioti A., Perros E., Anagnostopoulou U., et al. (2012) Viral epidemiology of acute exacerbations of chronic obstructive pulmonary disease. Pulm Pharmacol Ther 25: 12-18.
34. Djukanovic R., Harrison T., Johnston S., Gabbay F., Wark P., Thomson N., et al. (2014) The effect of inhaled IFN-beta on worsening of asthma symptoms caused by viral infections. A randomized trial. Am J Respir Crit Care Med 190: 145-154.
35. Edlmayr J., Niespodziana K., Popow-Kraupp T., Krzyzanek V., Focke-Tejkl M., Blaas D., et al. (2011) Antibodies induced with recombinant VP1 from human rhinovirus exhibit cross-neutralisation. Eur Respir J 37: 44-52.
36. Edwards M., Haas J., Panettieri R. Jr, Johnson M., Johnston S., (2007) Corticosteroids and beta2 agonists differentially regulate rhinovirus-induced interleukin-6 via distinct cis-acting elements. J Biol Chem 282: 15366-15375.
37. Fensterl V., Sen G., (2009) Interferons and viral infections. Biofactors 35: 14-20.
38. Footitt J., Mallia P., Durham A., Ho W., Trujillo-Torralbo M., Telcian A., et al. (2015) Oxidative and nitrosative stress and histone deacetylase-2 activity in exacerbations of chronic obstructive pulmonary disease. Chest DOI: 10.1378/chest.14-2637. [Epub ahead of print]
39. Gandhi A., Walsh E., Formica M., Hennessey P., Criddle M., Peterson D., et al. (2012) Factors associated with symptomatic rhinovirus infection in patients with COPD. J Clin Virol 55: 343-347.
40. George S., Garcha D., Mackay A., Patel A., Singh R., Sapsford R., et al. (2014) Human rhinovirus infection during naturally occurring COPD exacerbations. Eur Respir J 44: 87-96.
41. Gerke A., Tang F., Yang M., Foster E., Cavanaugh J., Polgreen P., (2013) Predicting chronic obstructive pulmonary disease hospitalizations based on concurrent influenza activity. COPD 10: 573-580.
42. Ghildyal R., Dagher H., Donninger H., De Silva D., Li X., Freezer N., et al. (2005) Rhinovirus infects primary human airway fibroblasts and induces a neutrophil chemokine and a permeability factor. J Med Virol 75: 608-615.
43. Gielen V., Johnston S., Edwards M., (2010) Azithromycin induces anti-viral responses in bronchial epithelial cells. Eur Respir J 36: 646-654.
44. Gielen V., Sykes A., Zhu J., Chan B., Macintyre J., Regamey N., et al. (2015) Increased nuclear suppressor of cytokine signaling 1 in asthmatic bronchial epithelium suppresses rhinovirus induction of innate interferons. J Allergy Clin Immunol 136: 177-188 e111.
45. Gill M., Bajwa G., George T., Dong C., Dougherty I., Jiang N., et al. (2010) Counterregulation between the Fc-RI pathway and antiviral responses in human plasmacytoid dendritic cells. J Immunol 184: 5999-6006.
46. Glanville N., Mclean G., Guy B., Lecouturier V., Berry C., Girerd Y., et al. (2013) Cross-serotype immunity induced by immunization with a conserved rhinovirus capsid protein. PLoS Pathog 9: e1003669.
47. Grissell T., Powell H., Shafren D., Boyle M., Hensley M., Jones P., et al. (2005) Interleukin-10 gene expression in acute virus-induced asthma. Am J Respir Crit Care Med 172: 433-439.
48. Grunberg K., Sharon R., Sont J., In 'T, Veen J., Van Schadewijk W., De Klerk E., et al. (2001) Rhinovirus-induced airway inflammation in asthma: effect of treatment with inhaled corticosteroids before and during experimental infection. Am J Respir Crit Care Med 164: 1816-1822.
49. Gulraiz F., Bellinghausen C., Bruggeman C., Stassen F., (2015) Haemophilus influenzae increases the susceptibility and inflammatory response of airway epithelial cells to viral infections. FASEB J 29: 849-858.
50. Hall D., Bates M., Guar L., Cronan M., Korpi N., Bertics P., (2005) The role of p38 MAPK in rhinovirus-induced monocyte chemoattractant protein-1 production by monocytic-lineage cells. J Immunol 174: 8056-8063.
51. Hanania N., Noonan M., Corren J., Korenblat P., Zheng Y., Fischer S., et al. (2015) Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies. Thorax 70: 748-756.
52. Hayden F., Herrington D., Coats T., Kim K., Cooper E., Villano S., et al. (2003) Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials. Clin Infect Dis 36: 1523-1532.
53. Hosseini S., Ghasemian E., Jamaati H., Tabaraie B., Amini Z., Cox K., (2015) Association between respiratory viruses and exacerbation of COPD: a case-control study. Infect Dis (Lond) 47: 523-529.
54. Hurst J., Vestbo J., Anzueto A., Locantore N., Mullerova H., Tal-Singer R., et al. (2010) Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 363: 1128-1138.
55. Hutchinson A., Ghimire A., Thompson M., Black J., Brand C., Lowe A., et al. (2007) A community-based, time-matched, case-control study of respiratory viruses and exacerbations of COPD. Respir Med 101: 2472-2481.
56. Ieki K., Matsukura S., Kokubu F., Kimura T., Kuga H., Kawaguchi M., et al. (2004) Double-stranded RNA activates RANTES gene transcription through co-operation of nuclear factor-kappaB and interferon regulatory factors in human airway epithelial cells. Clin Exp Allergy 34: 745-752.
57. Isaacs A., Lindenmann J., (1957) Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 147: 258-267.
58. Ishizuka S., Yamaya M., Suzuki T., Takahashi H., Ida S., Sasaki T., et al. (2003) Effects of rhinovirus infection on the adherence of Streptococcus pneumoniae to cultured human airway epithelial cells. J Infect Dis 188: 1928-1939.
59. Jackson D., Makrinioti H., Rana B., Shamji B., Trujillo-Torralbo M., Footitt J., et al. (2014) IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med 190: 1373-1382.
60. Jackson D., Trujillo-Torralbo M., Del-Rosario J., Bartlett N., Edwards M., Mallia P., et al. (2015) The influence of asthma control on the severity of virus-induced asthma exacerbations. J Allergy Clin Immunol 136: 497.
61. Jakab G., (1982) Immune impairment of alveolar macrophage phagocytosis during influenza virus pneumonia. Am Rev Respir Dis 126: 778-782.
62. Jartti T., Jartti L., Ruuskanen O., Soderlund-Venermo M., (2012) New respiratory viral infections. Curr Opin Pulm Med 18: 271-278.
63. Johnston S., Papi A., Bates P., Mastronarde J., Monick M., Hunninghake G., (1998) Low grade rhinovirus infection induces a prolonged release of IL-8 in pulmonary epithelium. J Immunol 160: 6172-6181.
64. Johnston S., Pattemore P., Sanderson G., Smith S., Lampe F., Josephs L., et al. (1995) Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 310: 1225-1229.
65. Karta M., Gavala M., Curran C., Wickert L., Keely P., Gern J., et al. (2014) LPS modulates rhinovirus-induced chemokine secretion in monocytes and macrophages. Am J Respir Cell Mol Biol 51: 125-134.
66. Kherad O., Kaiser L., Bridevaux P., Sarasin F., Thomas Y., Janssens J., et al. (2010) Upper-respiratory viral infection, biomarkers, and COPD exacerbations. Chest 138: 896-904.
67. Khetsuriani N., Kazerouni N., Erdman D., Lu X., Redd S., Anderson L., et al. (2007) Prevalence of viral respiratory tract infections in children with asthma. J Allergy Clin Immunol 119: 314-321.
68. Kloepfer K., Lee W., Pappas T., Kang T., Vrtis R., Evans M., et al. (2014) Detection of pathogenic bacteria during rhinovirus infection is associated with increased respiratory symptoms and asthma exacerbations. J Allergy Clin Immunol 133: 1301-1307.
69. Ko F., Ip M., Chan P., Chan M., To K., Ng S., et al. (2007) Viral etiology of acute exacerbations of COPD in Hong Kong. Chest 132: 900-908.
70. Korpi-Steiner N., Bates M., Lee W., Hall D., Bertics P., (2006) Human rhinovirus induces robust IP-10 release by monocytic cells, which is independent of viral replication but linked to type I interferon receptor ligation and STAT1 activation. J Leukoc Biol 80: 1364-1374.
71. Kupczyk M., Ten Brinke A., Sterk P., Bel E., Papi A., Chanez P., et al. (2014) Frequent exacerbators-a distinct phenotype of severe asthma. Clin Exp Allergy 44: 212-221.
72. Laza-Stanca V., Stanciu L., Message S., Edwards M., Gern J., Johnston S., (2006) Rhinovirus replication in human macrophages induces NF-kappaB-dependent tumor necrosis factor alpha production. J Virol 80: 8248-8258.
73. Linder J., Kraft D., Mohamed Y., Lu Z., Heil L., Tollefson S., et al. (2013) Human rhinovirus C: age, season, and lower respiratory illness over the past 3 decades. J Allergy Clin Immunol 131: 69-77.
74. Lopez-Souza N., Favoreto S., Wong H., Ward T., Yagi S., Schnurr D., et al. (2009) In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects. J Allergy Clin Immunol 123: 1384-1390.
75. Mallia P., Footitt J., Sotero R., Jepson A., Contoli M., Trujillo-Torralbo M., et al. (2012) Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 186: 1117-1124.
76. Mallia P., Message S., Gielen V., Contoli M., Gray K., Kebadze T., et al. (2011) Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med 183: 734-742.
77. Mallia P., Message S., Kebadze T., Parker H., Kon O., Johnston S., (2006) An experimental model of rhinovirus induced chronic obstructive pulmonary disease exacerbations: a pilot study. Respir Res 7: 116.
78. Martinello R., Esper F., Weibel C., Ferguson D., Landry M., Kahn J., (2006) Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease. J Infect 53: 248-254.
79. McCulloch D., Sears M., Jacob J., Lyon G., Burd E., Caliendo A., et al. (2014) Severity of rhinovirus infection in hospitalized adults is unrelated to genotype. Am J Clin Pathol 142: 165-172.
80. McKenna J., Bramley A., Skarbinski J., Fry A., Finelli L., Jain S., (2013) Asthma in patients hospitalized with pandemic influenza A (H1N1)pdm09 virus infection-United States, 2009. BMC Infect Dis 13: 57.
81. McManus T., Marley A., Baxter N., Christie S., O'Neill H., Elborn J., et al. (2008) Respiratory viral infection in exacerbations of COPD. Respir Med 102: 1575-1580.
82. McNamee L., Harmsen A., (2006) Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection. Infect Immun 74: 6707-6721.
83. Message S., Laza-Stanca V., Mallia P., Parker H., Zhu J., Kebadze T., et al. (2008) Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc Natl Acad Sci U S A 105: 13562-13567.
84. Miller E., Edwards K., Weinberg G., Iwane M., Griffin M., Hall C., et al. (2009) A novel group of rhinoviruses is associated with asthma hospitalizations. J Allergy Clin Immunol 123: 98-104.
85. Minosse C., Selleri M., Zaniratti M., Cappiello G., Longo R., Schifano E., et al. (2008) Frequency of detection of respiratory viruses in the lower respiratory tract of hospitalized adults. J Clin Virol 42: 215-220.
86. Mitchell I., Inglis J., Simpson H., (1978) Viral infection as a precipitant of wheeze in children. Combined home and hospital study. Arch Dis Child 53: 106-111.
87. Mortensen E., Louie J., Pertowski C., Cadwell B., Weiss E., Acosta M., et al. (2013) Epidemiology and outcomes of adults with asthma who were hospitalized or died with 2009 pandemic influenza A (H1N1)-California, 2009. Influenza Other Respir Viruses 7: 1343-1349.
88. Mosser A., Vrtis R., Burchell L., Lee W., Dick C., Weisshaar E., et al. (2005) Quantitative and qualitative analysis of rhinovirus infection in bronchial tissues. Am J Respir Crit Care Med 171: 645-651.
89. Myles P., Nguyen-Van-Tam J., Semple M., Brett S., Bannister B., Read R., et al. (2013) Differences between asthmatics and nonasthmatics hospitalised with influenza A infection. Eur Respir J 41: 824-831.
90. Nagarkar D., Bowman E., Schneider D., Wang Q., Shim J., Zhao Y., et al. (2010) Rhinovirus infection of allergen-sensitized and -challenged mice induces eotaxin release from functionally polarized macrophages. J Immunol 185: 2525-2535.
91. Nguyen-Van-Tam J., Openshaw P., Hashim A., Gadd E., Lim W., Semple M., et al. (2010) Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009). Thorax 65: 645-651.
92. Oliver B., Johnston S., Baraket M., Burgess J., King N., Roth M., et al. (2006) Increased proinflammatory responses from asthmatic human airway smooth muscle cells in response to rhinovirus infection. Respir Res 7: 71.
93. Oliver B., Lim S., Wark P., Laza-Stanca V., King N., Black J., et al. (2008) Rhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophages. Thorax 63: 519-525.
94. Ortega H., Liu M., Pavord I., Brusselle G., Fitzgerald J., Chetta A., et al. (2014) Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med 371: 1198-1207.
95. Pant S., Walters E., Griffiths A., Wood-Baker R., Johns D., Reid D., (2009) Airway inflammation and anti-protease defences rapidly improve during treatment of an acute exacerbation of COPD. Respirology 14: 495-503.
96. Papadopoulos N., Bates P., Bardin P., Papi A., Leir S., Fraenkel D., et al. (2000) Rhinoviruses infect the lower airways. J Infect Dis 181: 1875-1884.
97. Papi A., Bellettato C., Braccioni F., Romagnoli M., Casolari P., Caramori G., et al. (2006) Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 173: 1114-1121.
98. Papi A., Contoli M., (2011) Rhinovirus vaccination: the case against. Eur Respir J 37: 5-7.
99. Passariello C., Schippa S., Conti C., Russo P., Poggiali F., Garaci E., et al. (2006) Rhinoviruses promote internalisation of Staphylococcus aureus into non-fully permissive cultured pneumocytes. Microbes Infect 8: 758-766.
100. Perotin J., Dury S., Renois F., Deslee G., Wolak A., Duval V., et al. (2013) Detection of multiple viral and bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a pilot prospective study. J Med Virol 85: 866-873.
101. Price D., Fletcher M., Van Der Molen T., (2014) Asthma control and management in 8,000 European patients: the recognise asthma and link to symptoms and experience (REALISE) survey. NPJ Prim Care Respir Med 24: 14009.
102. Qiu Y., Zhu J., Bandi V., Atmar R., Hattotuwa K., Guntupalli K., et al. (2003) Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 168: 968-975.
103. Rabe K., Vermeire P., Soriano J., Maier W., (2000) Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 16: 802-807.
104. Ringshausen F., Tan A., Allander T., Borg I., Arinir U., Kronsbein J., et al. (2009) Frequency and clinical relevance of human bocavirus infection in acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 4: 111-117.
105. Rodriguez-Rieiro C., Carrasco-Garrido P., Hernandez-Barrera V., Lopez De Andres A., Jimenez-Trujillo I., Gil De, Miguel A., et al. (2012) Pandemic influenza hospitalization in spain (2009): incidence, in-hospital mortality, comorbidities and costs. Hum Vaccin Immunother 8: 443-447.
106. Rohde G., Borg I., Arinir U., Kronsbein J., Rausse R., Bauer T., et al. (2005) Relevance of human metapneumovirus in exacerbations of COPD. Respir Res 6: 150.
107. Rohde G., Wiethege A., Borg I., Kauth M., Bauer T., Gillissen A., et al. (2003) Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax 58: 37-42.
108. Roponen M., Yerkovich S., Hollams E., Sly P., Holt P., Upham J., (2010) Toll-like receptor 7 function is reduced in adolescents with asthma. Eur Respir J 35: 64-71.
109. Sajjan U., Ganesan S., Comstock A., Shim J., Wang Q., Nagarkar D., et al. (2009) Elastase- and LPS-exposed mice display altered responses to rhinovirus infection. Am J Physiol Lung Cell Mol Physiol 297: L931-L944.
110. Sajjan U., Jia Y., Newcomb D., Bentley J., Lukacs N., Lipuma J., et al. (2006) H. influenzae potentiates airway epithelial cell responses to rhinovirus by increasing ICAM-1 and TLR3 expression. FASEB J 20: 2121-2123.
111. Sajjan U., Wang Q., Zhao Y., Gruenert D., Hershenson M., (2008) Rhinovirus disrupts the barrier function of polarized airway epithelial cells. Am J Respir Crit Care Med 178: 1271-1281.
112. Santa-Olalla Peralta P., Cortes-Garcia M., Vicente-Herrero M., Castrillo-Villamandos C., Arias-Bohigas P., Pachon-Del Amo I., et al. (2010) Risk factors for disease severity among hospitalised patients with 2009 pandemic influenza A (H1N1) in Spain, April-December 2009. Euro Surveill 15: pii= 19667.
113. Schneider D., Ganesan S., Comstock A., Meldrum C., Mahidhara R., Goldsmith A., et al. (2010) Increased cytokine response of rhinovirus-infected airway epithelial cells in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 182: 332-340.
114. Seemungal T., Harper-Owen R., Bhowmik A., Moric I., Sanderson G., Message S., et al. (2001) Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164: 1618-1623.
115. Senior K., (2002) FDA panel rejects common cold treatment. Lancet Infect Dis 2: 264.
116. Sheppard P., Kindsvogel W., Xu W., Henderson K., Schlutsmeyer S., Whitmore T., et al. (2003) IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4: 63-68.
117. Singanayagam A., Glanville N., Walton R., Aniscenko J., Pearson R., Pinkerton J., et al. (2015) A short-term mouse model that reproduces the immunopathological features of rhinovirus-induced exacerbation of COPD. Clin Sci (Lond) 129: 245-258.
118. Singh M., Lee S., Porter P., Xu C., Ohno A., Atmar R., et al. (2010) Human rhinovirus proteinase 2A induces Th1 and Th2 immunity in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol 125: 1369-1378.
119. Soler M., Matz J., Townley R., Buhl R., O'Brien J., Fox H., et al. (2001) The anti-IGE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. Eur Respir J 18: 254-261.
120. Sonnenfeld G., Hudgens R., (1986) Effect of sidestream and mainstream smoke exposure on in vitro interferon-alpha/beta production by L-929 cells. Cancer Res 46: 2779-2783.
121. Spurrell J., Wiehler S., Zaheer R., Sanders S., Proud D., (2005) Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection. Am J Physiol Lung Cell Mol Physiol 289: L85-L95.
122. Sun K., Metzger D., (2008) Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nat Med 14: 558-564.
123. Sykes A., Edwards M., Macintyre J., Del Rosario A., Bakhsoliani E., Trujillo-Torralbo M., et al. (2012) Rhinovirus 16-induced IFN-alpha and IFN-beta are deficient in bronchoalveolar lavage cells in asthmatic patients. J Allergy Clin Immunol 129: 1506-1514.
124. Sykes A., Edwards M., Macintyre J., Del Rosario A., Gielen V., Haas J., et al. (2013) TLR3, TLR4 and TLRs7-9 induced interferons are not impaired in airway and blood cells in well controlled asthma. PLoS One 8: e65921.
125. Sykes A., Macintyre J., Edwards M., Del Rosario A., Haas J., Gielen V., et al. (2014) Rhinovirus-induced interferon production is not deficient in well controlled asthma. Thorax 69: 240-246.
126. Tan W., Xiang X., Qiu D., Ng T., Lam S., Hegele R., (2003) Epidemiology of respiratory viruses in patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease. Am J Med 115: 272-277.
127. Traub S., Nikonova A., Carruthers A., Dunmore R., Vousden K., Gogsadze L., et al. (2013) An anti-human ICAM-1 antibody inhibits rhinovirus-induced exacerbations of lung inflammation. PLoS Pathog 9: e1003520.
128. Turner R., Wecker M., Pohl G., Witek T., McNally E., St George R., et al. (1999) Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial. JAMA 281: 1797-1804.
129. Unger B., Faris A., Ganesan S., Comstock A., Hershenson M., Sajjan U., (2012) Rhinovirus attenuates non-typeable Hemophilus influenzae -stimulated IL-8 responses via TLR2-dependent degradation of Irak-1. PLoS Pathog 8: e1002969.
130. Vallet C., Pons-Catalano C., Mandelcwajg A., Wang A., Raymond J., Lebon P., et al. (2009) Human bocavirus: a cause of severe asthma exacerbation in children. J Pediatr 155: 286-288.
131. Vestbo J., Hurd S., Agusti A., Jones P., Vogelmeier C., Anzueto A., et al. (2013) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187: 347-365.
132. Wang J., Kwon H., Jang Y., (2009) Rhinovirus enhances various bacterial adhesions to nasal epithelial cells simultaneously. Laryngoscope 119: 1406-1411.
133. Wark P., Johnston S., Bucchieri F., Powell R., Puddicombe S., Laza-Stanca V., et al. (2005) Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 201: 937-947.
134. Wark P., Johnston S., Moric I., Simpson J., Hensley M., Gibson P., (2002) Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J 19: 68-75.
135. Wark P., Tooze M., Powell H., Parsons K., (2013) Viral and bacterial infection in acute asthma and chronic obstructive pulmonary disease increases the risk of readmission. Respirology 18: 996-1002.
136. Wenzel S., Ford L., Pearlman D., Spector S., Sher L., Skobieranda F., et al. (2013) Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med 368: 2455-2466.
137. Wilkinson T., Hurst J., Perera W., Wilks M., Donaldson G., Wedzicha J., (2006) Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD. Chest 129: 317-324.
138. Williams J., Crowe J. Jr, Enriquez R., Minton P., Peebles R. Jr, Hamilton R., et al. (2005) Human metapneumovirus infection plays an etiologic role in acute asthma exacerbations requiring hospitalization in adults. J Infect Dis 192: 1149-1153.
139. Zhu Z., Tang W., Gwaltney J. Jr, Wu Y., Elias J., (1997) Rhinovirus stimulation of interleukin-8 in vivo and in vitro: role of NF-kappaB. Am J Physiol 273: L814-L824.
140. Zhu Z., Tang W., Ray A., Wu Y., Einarsson O., Landry M., et al. (1996) Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation. J Clin Invest 97: 421-430.